Genomic characteristics of PD-L1-Induced resistance to EGFR-TKIs in lung adenocarcinoma

The co-occurrence of PD-L1 positivity and EGFR mutations in advanced NSCLC often limits EGFR-TKIs effectiveness, with unclear mechanisms.